One often-overlooked effect of COVID-19: Patients often exhibit bleeding events, ranging from simple skin lesions to overt emergencies: https://t.co/Ivjl641Sha
Stem cell treatments may represent a new treatment option to avoid amputation for the most stubborn, nonhealing foot ulcers: https://t.co/uUhaNPuby1 #woundcare#regenerativemedicine
There’s still time to visit our virtual booth at #SAWCSpring2021 Virtual Wound Care. We look forward to talking with you there! https://t.co/rRKUKbP0iI
SANUWAVE is at the forefront of improving the standard of care for advanced #woundcare using our energy first protocol: https://t.co/Dezxj4Xvjq #DFU#podiatry
Read about a novel way to treat diabetic foot ulcers using regenerative therapy that might also benefit heart disease and liver conditions: https://t.co/5pL8HWBpQX
Learn about our Energy First protocol at SuperBones SuperWounds East. Eric Gruntfest, COC at Reimbursement and Billing Corp., will also discuss reimbursement for our Energy First products on Sunday, April 18, 8:45-9:00 a.m. ET: https://t.co/a8P4bFPMdN #DFU#podiatry
Biophysical approaches to advanced wound care are advancing rapidly — here are six from the 2020 Symposium on Advanced Wound Care: https://t.co/iBOrpfMrx4
As the leading end-to-end advanced wound care solution, SANUWAVE® addresses the entire wound care pathway through our portfolio of noninvasive and biological-response therapeutics.